[HTML][HTML] Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy
Adoptive T-cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) can induce tumor
regression in up to 50% or more of patients with unresectable metastatic melanoma …
regression in up to 50% or more of patients with unresectable metastatic melanoma …
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8 (+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy.
JA Chacon, RC Wu, P Sukhumalchandra, JJ Molldrem… - Plos one, 2013 - europepmc.org
Adoptive T-cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) can induce tumor
regression in up to 50% or more of patients with unresectable metastatic melanoma …
regression in up to 50% or more of patients with unresectable metastatic melanoma …
Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8. sup.+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy
JA Chacon, RC Wu, P Sukhumalchandra, JJ Molldrem… - PLoS ONE, 2013 - go.gale.com
Adoptive transfer of ex vivo expanded autologous tumor-infiltrating lymphocytes together
followed by one to two cycles of high-dose IL-2 therapy has emerged in multiple Phase II …
followed by one to two cycles of high-dose IL-2 therapy has emerged in multiple Phase II …
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8 (+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy
JA Chacon, RC Wu, P Sukhumalchandra… - PloS …, 2013 - pubmed.ncbi.nlm.nih.gov
Adoptive T-cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) can induce tumor
regression in up to 50% or more of patients with unresectable metastatic melanoma …
regression in up to 50% or more of patients with unresectable metastatic melanoma …
Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy
JA Chacon, RC Wu, P Sukhumalchandra… - PloS …, 2013 - mdanderson.elsevierpure.com
Adoptive T-cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) can induce tumor
regression in up to 50% or more of patients with unresectable metastatic melanoma …
regression in up to 50% or more of patients with unresectable metastatic melanoma …
[PDF][PDF] Co-Stimulation through 4-1BB
JA Chacon, RC Wu, P Sukhumalchandra… - CD137 Improves the …, 2013 - Citeseer
Adoptive T-cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) can induce tumor
regression in up to 50% or more of patients with unresectable metastatic melanoma …
regression in up to 50% or more of patients with unresectable metastatic melanoma …
Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy.
JA Chacon, RC Wu, P Sukhumalchandra… - PLoS …, 2013 - search.ebscohost.com
Adoptive T-cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) can induce tumor
regression in up to 50% or more of patients with unresectable metastatic melanoma …
regression in up to 50% or more of patients with unresectable metastatic melanoma …
[PDF][PDF] Co-Stimulation through 4-1BB
JA Chacon, RC Wu, P Sukhumalchandra… - CD137 Improves the …, 2013 - researchgate.net
Adoptive T-cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) can induce tumor
regression in up to 50% or more of patients with unresectable metastatic melanoma …
regression in up to 50% or more of patients with unresectable metastatic melanoma …
[引用][C] Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy
JA Chacon, RC Wu, P Sukhumalchandra… - PLoS …, 2013 - ui.adsabs.harvard.edu
Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma
Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy - NASA/ADS Now on home page ads …
Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy - NASA/ADS Now on home page ads …
[HTML][HTML] Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy
JA Chacon, RC Wu, P Sukhumalchandra, JJ Molldrem… - PLoS ONE, 2013 - ncbi.nlm.nih.gov
Adoptive T-cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) can induce tumor
regression in up to 50% or more of patients with unresectable metastatic melanoma …
regression in up to 50% or more of patients with unresectable metastatic melanoma …